Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/16304
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTalwar, V-
dc.contributor.authorWurm, P-
dc.contributor.authorBankart, MJ-
dc.contributor.authorGershlick, AH-
dc.contributor.authorde Caestecker JS-
dc.date.accessioned2012-10-24T09:00:57Z-
dc.date.available2012-10-24T09:00:57Z-
dc.date.issued2010-07-
dc.identifier.citationALIMENT PHARMACOL THER, 2010, 32 (2), pp. 191-199-
dc.identifier.urihttp://hdl.handle.net/2381/16304-
dc.description.abstractGastro-oesophageal reflux (GER) and coronary artery disease commonly co-exist. Coronary artery disease patients may mistake GER-induced pain for cardiac pain or GER might provoke angina.-
dc.formatmetadata-
dc.language.isoeng-
dc.sourcePubMed-
dc.source.urihttp://www.ncbi.nlm.nih.gov/pubmed/-
dc.subject2-Pyridinylmethylsulfinylbenzimidazoles-
dc.subjectAdult-
dc.subjectAged-
dc.subjectAged-
dc.subject80 and over-
dc.subjectAnti-Ulcer Agents-
dc.subjectChest Pain-
dc.subjectCoronary Angiography-
dc.subjectCoronary Artery Disease-
dc.subjectCross-Over Studies-
dc.subjectDouble-Blind Method-
dc.subjectFemale-
dc.subjectGastroesophageal Reflux-
dc.subjectHumans-
dc.subjectMale-
dc.subjectMiddle Aged-
dc.subjectQuality of Life-
dc.titleClinical trial: chest pain caused by presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole vs. placebo.-
dc.typeJournal Article-
dc.identifier.doi10.1111/j.1365-2036.2010.04336.x-
dc.identifier.eissn1365-2036-
dc.identifier.piiAPT4336-
dc.description.irispid18314-
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
There are no files associated with this item.


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.